The SightDX Parasight Malaria Detection Platform from Israel’s Sight Diagnostics is to be introduced into India; Israel’s LifeSeal, the no-leak sealant solution for patients who have undergone gastrointestinal (GI) surgery, has received CE approval for use in the European Union, and much more.
By: Michael Ordman
ISRAEL’S MEDICAL ACHIEVEMENTS
Malaria detection for India
The SightDX Parasight Malaria Detection Platform from Israel’s Sight Diagnostics is to be introduced into India. Approximately 880,000 cases of malaria were reported in India in 2013. http://www.livemint.com/Companies/tawvlTnMXHEnoHjT4K9qvN/Becton-Dickinson-brings-4minute-malaria-detection-kit-to-I.html
EU and US boosts for surgical sealant
Israel’s LifeSeal, the no-leak sealant solution for patients who have undergone gastrointestinal (GI) surgery, has received CE approval for use in the European Union. LifeSeal has also been fast-tracked for approval by the US FDA through its Expedited Access Pathway (EAP)
New anti-bacteria coating
Researchers at Ben-Gurion University have developed an innovative anti-biofilm coating. The anti-adhesive patches can prevent destructive bacterial biofilm forming on metal surfaces. It could be used on medical implants, devices and surgical equipment and even on ships and bridges.
Automatic diagnosis from radiology images
Tel Aviv University Professor Hayit Greenspan has developed a wide variety of “deep learning” tools to facilitate computer-assisted diagnosis of X-rays, CTs and MRIs, freeing radiologists to attend to complex cases that require their full attention and skills.
US Jews study trauma in Israel
Social work students from Yeshiva University’s Wurzweiler School of Social Work are in Israel to attend an intensive course on trauma, emergency response and recovery. It features workshops on trauma intervention, and real-time emergency response simulation.
Israel and US scientists join up to beat cancer
Israel’s Technion and New York University’s Langone Medical Center have begun a research project, targeting metastatic melanoma and mesothelioma. They will test the ability of a nanotechnology based on so-called “nanoghosts” using stem cells to home in on cancer cells.
Progress for DNA blood test
The DNA diagnostic breakthrough from the Hebrew University of Jerusalem has been funded. Priority is now for a diagnostic tool for neurodegenerative, cardiovascular and autoimmune diseases plus a blood test for the early detection of multiple diseases at their asymptomatic stage.
Mayo Clinic to work with Israeli startups
The US medical organization Mayo Clinic is launching the Mayo Clinic Israeli Startups Initiative. It will encourage collaboration among Israeli health care startup companies and Mayo Clinic and fund joint R&D to accelerate availability of medical innovations to the public.
Click here for all of this week’s Good News from Israel.